Silvana Yovanof, M.D.
Endocrinology, Diabetes & Metabolism Physician · Monongahela, PA
Silvana Yovanof, M.D. is an endocrinology, diabetes & metabolism physician with a practice address in Monongahela, Pennsylvania, and NPI 1770561375, issued on Jan 4, 2006. Check the license (Pennsylvania MD046661L, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Silvana Yovanof
- Credential
- M.D.
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- MD046661L PA
Self-reported in NPPES; status is on the state search - Practice location
- 420 W Main St, Monongahela, PA 15063
- Phone
- (724) 258-8680
- Enumerated
- Jan 4, 2006
- Record last updated
- Mar 17, 2018 (not updated in 8 years: call before relying on the address or phone)
- Fax
- (724) 258-2920
- Medicaid ID
- MA1423389 PA
- Medicare enrollment
- Enrolled (PECOS I20130506000068); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 485 in Pennsylvania → Look up another NPI →
Verify Silvana Yovanof in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD046661LCheck the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
93% more Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
5,076 Medicare Part D claims for 232 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 20% of claims. 25 claims were for opioids.
Most prescribed
- Levothyroxine Sodium319 claims
- Ozempic254 claims
- Rosuvastatin Calcium216 claims
- Metformin Hcl196 claims
- Atorvastatin Calcium169 claims
- Amlodipine Besylate166 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $409.63
12 payments; by number, the most common kind was food and beverage; the largest payer was Novo Nordisk Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Silvana Yovanof among 485 endocrinology, diabetes & metabolism physician records in Pennsylvania
Silvana Yovanof, M.D. is one of 485 endocrinology, diabetes & metabolism physician records with a practice address in Pennsylvania. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 7% of them.
- NPI issued2006 · 7% of these records are older, 59% newer
- In a Medicare fileYes · 84% of these records are
- In the CMS Doctors and Clinicians fileYes · 69% of these records are
- Graduated1985 · median 2004 among the 334 with a school on file
- Record last updated2018 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Pennsylvania
There are 485 endocrinology, diabetes & metabolism physician records in Pennsylvania.
All 485 in Pennsylvania → Every provider in Monongahela → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Kamala Rajupet, M.D.Natrona Heights, PA 150651467470229
- Paul Jerome Custodio, M.D.New Kensington, PA 150681093997280
- Chelsea Loughner, DONew Kensington, PA 150681417536889
- Nishit VaghasiaNew Kensington, PA 150681194016808
- Elisabeth Bergman, MDWexford, PA 150901871605527
- Roy Guinto, D.O.Wexford, PA 150901427378884
- Farhad Hasan, M.D.Wexford, PA 150901396995437
- Jennifer Pennock, MDWexford, PA 150901962475681
Common questions
What is Silvana Yovanof, M.D.'s NPI number?
Silvana Yovanof, M.D.'s National Provider Identifier (NPI) is 1770561375, issued on Jan 4, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Silvana Yovanof, M.D. located?
The NPPES record lists a practice address at 420 W Main St, Monongahela, PA, 15063. Phone: (724) 258-8680. Providers update this record themselves, so call before visiting.
How can I verify Silvana Yovanof, M.D.'s license?
NPPES lists Pennsylvania license number MD046661L, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Silvana Yovanof, M.D. prescribe under Medicare Part D?
In 2024, Silvana Yovanof, M.D. had 5,076 Medicare Part D claims for 232 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.